Burrowes Jerrilynn D, Larive Brett, Chertow Glenn M, Cockram David B, Dwyer Johanna T, Greene Tom, Kusek John W, Leung June, Rocco Michael V
Department of Nutrition, C.W. Post Campus of Long Island University, School of Health 720 Northern Blvd., Brookville, NY 11548, USA.
Nephrol Dial Transplant. 2005 Dec;20(12):2765-74. doi: 10.1093/ndt/gfi132. Epub 2005 Oct 4.
Anorexia is an important cause of protein-energy malnutrition (PEM) in haemodialysis patients. We investigated whether self-reported appetite was associated with death and hospitalization in subjects enrolled in the Hemodialysis (HEMO) Study.
The HEMO Study was a 7-year, multicentre, randomized trial (N = 1846), which examined the effects of dialysis dose and membrane flux on mortality and morbidity. Three questions from the Appetite and Diet Assessment Tool (ADAT) were used to determine whether appetite had changed over time in the randomized treatment groups. The relations among ADAT scores, dietary protein and energy intakes, biochemical and anthropometric measures, and quality of life were assessed. We used Cox proportional hazards models to evaluate the relative risks of death and hospitalization associated with static and dynamic ADAT scores, adjusted for demographic factors, dose and flux assignments, and co-morbidity.
The average length of follow-up was 2.84 years. After adjusting for demographic factors and randomized treatment assignments, there was a significant association between poorer self-reported appetite and death (RR 1.52, 95% CI 1.16-1.98); however, the association became non-significant with further adjustment for co-morbidity (RR 1.23, 95% CI 0.94-1.62). Poorer appetite was unequivocally associated with increased hospitalization rates (multivariable RR 1.35, 95% CI 1.13-1.61). The longitudinal effect of worsening appetite from baseline to 1 year was not associated with mortality or hospitalization rate after adjusting for co-morbidity.
The association between appetite and death was confounded by co-morbidity. Self-reported appetite was associated with hospitalization rate in haemodialysis patients and, thus, it may be a useful screening tool for this outcome. Patients who report poor or very poor appetites should be monitored, and they should receive more comprehensive nutritional assessments.
厌食是血液透析患者蛋白质-能量营养不良(PEM)的一个重要原因。我们调查了血液透析(HEMO)研究中受试者自我报告的食欲是否与死亡和住院相关。
HEMO研究是一项为期7年的多中心随机试验(N = 1846),该试验研究了透析剂量和膜通量对死亡率和发病率的影响。使用食欲和饮食评估工具(ADAT)中的三个问题来确定随机治疗组中食欲是否随时间变化。评估了ADAT评分、膳食蛋白质和能量摄入量、生化和人体测量指标以及生活质量之间的关系。我们使用Cox比例风险模型来评估与静态和动态ADAT评分相关的死亡和住院的相对风险,并对人口统计学因素、剂量和通量分配以及合并症进行了调整。
平均随访时间为2.84年。在调整了人口统计学因素和随机治疗分配后,自我报告的食欲较差与死亡之间存在显著关联(风险比1.52,95%置信区间1.16 - 1.98);然而,在进一步调整合并症后,该关联变得不显著(风险比1.23,95%置信区间0.94 - 1.62)。食欲较差与住院率增加明确相关(多变量风险比1.35,95%置信区间1.13 - 1.61)。在调整合并症后,从基线到1年食欲恶化的纵向效应与死亡率或住院率无关。
食欲与死亡之间的关联被合并症所混淆。自我报告的食欲与血液透析患者的住院率相关,因此,它可能是该结果的一个有用筛查工具。应监测报告食欲差或非常差 的患者,并且他们应接受更全面的营养评估。